In order to confirm that the detrimental effect of treatment with serum from delirium patients on cell proliferation and apoptosis was due to the higher levels of IL6 in the serum samples of the same patients, we exposed cells to treatment with serum from COVID-19 patients together with an antibody against IL6 (Fig. 1c). The gene discussed is IL6; the disease is delirium.